Devosia limi

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Devosia limi is a Gram-negative, non-spore-forming, strictly aerobic, non-motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. Devosia limi is likely to be transient and not a long-term gut coloniser. (Kumar2008; Vanparys2005)



  • This organism has been recovered from human faeces and enriched nitrifying community. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread. Pathogenicity status unknown, or very unlikely to be pathogenic. Likely to be transient and not a long-term gut commensal.
    • QUIRKS
  • Obligate aerobe; unlikely to be a gut coloniser.
    • GENERAL CHARACTERISTICS (Kumar2008); (Vanparys2005);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin;
  • Active enzymes:
  • alkaline phosphatase; acid phosphatase; N-Ac β-glucosaminidase; catalase; β-galactosidase; β-glucosidase; Leu arylamidase; oxidase; naphthol-ASBI-P;
    • SPECIAL FEATURES (Kumar2008); (Vanparys2005);
    Character Response
  • ✗
  • Metabolites not produced:
  • indole;
  • ✗
  • Nitrate:
  • not reduced
    • RESPONSE TO ANTIBIOTICS (Kumar2008); (Vanparys2005);
    Class Active Resistant
  • Penicillins:
  • ampicillin;
  • Quinolines:
  • ciprofloxacin;
  • Aminoglycosides:
  • amikacin; gentamicin; kanamycin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • chloramphenicol;
  • Vancomycins:
  • vancomycin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Proteobacteria Class:  Alphaproteobacteria Order:  Hyphomicrobiales Family:  Devosiaceae Genus:  Devosia Gram stain:  neg O2 Relation.:  strictly aerobic Spore:  No spore Motility:  Sessile Morphology:  Rod
    Health:  Unknown
    Source:  human faeces and enriched nitrifying community
    		Aesculin:  + Urea:  neg Gelatin:  neg
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Glucose:  neg
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  neg Glucose:  neg Mannose:  neg Maltose:  neg N_Acetyl_glucosamine:  neg Gluconate:  neg Mannitol:  neg Adipate:  neg Caprate:  neg Citrate:  neg Malate:  neg Phenylacetate:  neg
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  + Catalase:  + Urease:  neg Ac-β-glcamnd:  + α-Fucosidase:  neg β-Galactosidase:  + α-Glucosidase:  neg β-Glucosidase:  + β-Glucuronidase:  neg α-Mannosidase:  neg ArgDH:  neg Chymotrypsin:  neg CystineAA:  neg LeuAA:  + AlkalineP:  + AcidP:  + EstLip(C8):  w Lipase:  neg
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Indole:  neg
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    ampicillin:  S(10; disc)
    amikacin:  R(30; disc)
    gentamicin:  R(10; disc)
    kanamycin:  R(30; disc)
    ciprofloxacin:  R(5; disc)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    tetracycline:  Var(MIC50): 30; disc), MIC90: Var(30; disc
    vancomycin:  S(30; disc)
    rifampicin:  R(5; disc)
    chloramphenicol:  R(30; disc)

    References

    SPECIFIC REFERENCES FOR DEVOSIA LIMI
  • Kumar2008 - Devosia chinhatensis sp. nov., isolated from a hexachlorocyclohexane (HCH) dump site in India.
  • Vanparys2005 - Devosia limi sp. nov., isolated from a nitrifying inoculum.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR DEVOSIA LIMI
  • Yang2020 - Species-Level Analysis of Human Gut Microbiota With Metataxonomics.
  • Yang2020a - Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families
  • ...............................
    • Added: December 15, 2021